Investors & Media - BrainStorm Cell Therapeutics

News

Press Releases

Month Year

Investor Alerts

Jun 26, 2018

BrainStorm Provides Update on "Right to Try" Policy

Webcast and Conference Call at 8:30am Eastern Time Today NEW YORK and PETACH TIKVA, Israel, June 26, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of...
Jun 25, 2018

BrainStorm to Host Tomorrow a Conference Call to Announce Its "Right To Try" Policy

Conference Call and Live Webcast at 8:30am Eastern Time

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will hold a conference call tomorrow, June 26 th at 08:30am...
Jun 7, 2018

BrainStorm Announces Exercise of Warrants Resulting in Cash Proceeds of ~$12.3 Million at $5 Share

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced it has entered into a Warrant Exercise...
Jun 1, 2018

BrainStorm to Host Call Following President Trump's Citing of Company's ALS Treatment During "Right-to-Try" Bill Signing

Conference call and live webcast on June 7th at 8:15am EDT

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that the company will host a "Right-to-Try"...
May 30, 2018

BrainStorm Cell Therapeutics to Provide Corporate Update at the BIO International Convention

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the Company will present a corporate...